Day: December 4, 2020

OSE Immunotherapeutics and Nantes University Hospital Announce Initiation of a Phase 1/2 Clinical Trial to Evaluate CD28 Antagonist FR104 in Patients Undergoing Renal Transplantation

University Hospital of Nantes will sponsor and conduct the clinical trialOSE Immunotherapeutics will provide its FR104 productPost-transplant immune response is...

Akari Therapeutics Announces Publication in American Journal of Pathology Highlighting Potential of Nomacopan in Treatment of Uveitis and Retinal Disease

New data highlight role of leukotriene B4 (LTB4) in the pathophysiology of retinal inflammation and degenerationIn the experimental allergic uveitis...

error: Content is protected !!